FAS Wealth Partners’s Acura Pharmaceuticals ACUR Stock Holding History

FAS Wealth Partners’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-16,396	Closed	-$13K	–	172
2016 Q4	$13K	Hold	16,396	–	–	﹤0.01%	156
2016 Q3	$26K	Hold	16,396	–	–	0.01%	150
2016 Q2	$30K	Hold	16,396	–	–	0.01%	144
2016 Q1	$46K	Hold	16,396	–	–	0.02%	122
2015 Q4	$41K	Hold	16,396	–	–	0.02%	129
2015 Q3	$39K	Sell	16,396 -1	-0%	-$3	0.02%	109
2015 Q2	$81K	Hold	16,397	–	–	0.04%	111
2015 Q1	$65K	Hold	16,397	–	–	0.03%	104
2014 Q4	$37K	Hold	16,397	–	–	0.02%	93
2014 Q3	$64K	Hold	16,397	–	–	0.04%	86
2014 Q2	$89K	Hold	16,397	–	–	0.05%	90
2014 Q1	$120K	Sell	16,397 -2,000	-11%	-$17.4K	0.08%	87
2013 Q4	$154K	Buy	+18,397	New	+$155K	0.09%	89

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

FAS Wealth Partners's ACUR Position: Q1 2017 in Review

FAS Wealth Partners sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 16,396 shares — an estimated $13K sold.

FAS Wealth Partners first reported a position in ACUR in Q4 2013 and held it in 13 quarters. The position peaked at $154K in Q4 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

FAS Wealth Partners reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
FAS Wealth Partners sold 16,396 Acura Pharmaceuticals shares in Q1 2017, an estimated $13K.
FAS Wealth Partners first reported a position in Acura Pharmaceuticals in Q4 2013 and held it in 13 quarters.
FAS Wealth Partners's Acura Pharmaceuticals position peaked at $154K in Q4 2013.
3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on FAS Wealth Partners's 13F filing for Q1 2017, filed 8 May 2017.